-
Most Recent
Search Results
176 results for yuii
ANCN Stock: 10 Things to Know as Anchiano Therapeutics Rockets Higher
ANCN stock is an early stage company engaged in clinical trials for rare liver, lung and skin diseases with no FDA-approved options now.
PPBT Stock: 9 Things for Investors to Know About Purple Biotech as Shares Surge
Purple Biotech (PPBT) stock is heading higher on Wednesday with heavy trading of the shares despite a lack of news about the company.
Titan Pharmaceuticals News: 8 Things for TTNP Stock Investors to Know about the JT Pharma Deal
Titan Pharmaceuticals (TTNP) is making news on Wednesday after announcing a deal with JT Pharma to acquire one of its assets.
Exact Sciences News: Why EXAS Stock Is Shooting 18% Higher Today
Exact Sciences (EXAS) stock was flying high on Tuesday following a flurry of news from the molecular diagnostics company.
Catabasis Pharmaceuticals News: Why CATB Stock Is Plummeting 69% Today
Catabasis Pharmaceuticals (CATB) news for Tuesday includes incredibly poor results from a clinical trial hammering CATB stock hard.
Cassava Sciences News: SAVA Stock Surges 38% on Insider Buying
Cassava Sciences (SAVA) news for Friday concerning insider buying from leaders at the company has SAVA stock on the rise.
Merger News: Why NEOS Stock and AYTU Stock Are Climbing Today
NEOS stock holders will get AYTU stock in this no-cash merger transaction. Today’s vote has the support of two proxy advisory firms.
KMPH Stock: Why Twitter Thinks KemPharm Is the New GME Short Squeeze
KemPharm (KMPH) stock is gaining interest on Twitter (TWTR) from retail traders that think it might be the next GameStop (GME).
Why Is Greenwich Lifesciences (GLSI) Stock Up Today?
Greenwich Lifesciences (GLSI) stock is heading higher on Tuesday after the FDA lifted a hold on a Phase III clinical trial.
ZimVie Spinoff: 12 Things for Zimmer Biomet (ZBH) Stock Investors to Know
Zimmer Biomet (ZBH) is preparing for a ZimVie spinoff with a new U.S. Securities and Exchange Commission (SEC) filing today.
Karuna Therapeutics (KRTX) Stock Soars 64% on Positive Clinical Data
Karuna Therapeutics (KRTX) stock is rocketing higher on Monday thanks to results from a Phase 3 EMERGENT-2 trial to treat schizophrenia.
Why Is Reata Pharmaceuticals (RETA) Stock Up 175% Today?
Reata Pharmaceuticals (RETA) stock is rocketing higher on Wednesday following approval from the FDA for one of its drugs.
Aptevo Therapeutics News: Why APVO Stock Is Falling 15% Today
Aptevo Therapeutics (APVO) news for Wednesday includes APVO stock taking a fall after a strong rally yesterday on clinical trial results.
ADMA Stock: The Big FDA News Boosting ADMA Biologics Today
Today, ADMA stock is a big mover as the company announced a very bullish FDA approval allowing the company to scale its core product.
3 Stocks That Deliver Dividends — Plus Growth
The highest yielding stocks are not always the best bet for investors. Finding dividends plus appreciation is the goal; here are 3 stocks that fit…
KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today
Pasithea Therapeutics (KTTA) stock is heading higher on heavy trading Thursday even without any recent news from the biotech company.
Why Is Axsome Therapeutics (AXSM) Stock Down Today?
Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week.
Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today?
Ensyce Biosciences (ENSC) stock is taking a beating on Friday after the clinical-stage biotech company announced $8 million in financing.
Why Is CASI Pharmaceuticals (CASI) Stock Up 700% Today?
CASI Pharmaceuticals (CASI) stock rocketed higher in pre-market trading this morning but it’s not due to any positive news from the company.
MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today
MannKind (MNKD) stock is taking a beating on Monday after releasing an update to investors concerning news from the FDA for Tyvaso DPI.
GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket
Guardion Health Science (GHSI) stock is taking off on Wednesday thanks to a presentation taking place today and heavy trading.
4 – 8 of 176 results
